Clinical trial
GLIDE-HF Registry: A Prospective, Single-Center, Observational Cohort of Patients With Obesity-Related Heart Failure With Preserved Ejection Fraction, With GLP-1/GIP Receptor Agonist Therapy as an Observed Exposure and Serial Exercise Echocardiographic Phenotyping
NCT07787936 is registered in ClinicalTrials.gov with Miedziowe Centrum Zdrowia SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- GLIDE-HF Registry: A Prospective, Single-Center, Observational Cohort of Patients With Obesity-Related Heart Failure With Preserved Ejection Fraction, With GLP-1/GIP Receptor Agonist Therapy as an Observed Exposure and Serial Exercise Echocardiographic Phenotyping
- Lead sponsor
- Miedziowe Centrum Zdrowia SA
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 1, 2027
- Completion date
- January 1, 2033
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diastolic heart failure, heart failure with preserved ejection fraction, iron deficiency, obesity, pulmonary hypertension